amifostine anhydrous has been researched along with Leg Length Inequality in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Leg Length Inequality: A condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damron, TA | 2 |
| Spadaro, JA | 2 |
| Horton, JA | 1 |
| Margulies, BS | 1 |
| Strauss, JA | 1 |
| Farnum, CE | 1 |
| Tamurian, RM | 1 |
| Damron, LA | 1 |
2 other studies available for amifostine anhydrous and Leg Length Inequality
| Article | Year |
|---|---|
Combinations of radioprotectants spare radiation-induced damage to the physis.
Topics: Amifostine; Animals; Body Weight; Bone Density; Bone Development; Drug Therapy, Combination; Femur; | 2004 |
Sparing of radiation-induced damage to the physis: fractionation alone compared to amifostine pretreatment.
Topics: Amifostine; Animals; Bone Development; Dose Fractionation, Radiation; Femur; Leg Length Inequality; | 2000 |